Published in Exp Ther Med on November 25, 2015
Atherosclerosis--an inflammatory disease. N Engl J Med (1999) 59.28
NF-kappa B: ten years after. Cell (1996) 12.80
NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res (2000) 8.62
Signal transduction by the c-Jun N-terminal kinase (JNK)--from inflammation to development. Curr Opin Cell Biol (1998) 6.28
Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension (1995) 2.49
The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol (2005) 2.07
Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis (1984) 1.88
Molecular mechanism of TNF signaling and beyond. Cell Res (2005) 1.66
Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal (2007) 1.66
Matrix-driven cell size change modulates aortic endothelial cell proliferation and sheet migration. Am J Pathol (1988) 1.49
Endothelial cell inflammatory responses to tumor necrosis factor alpha. Ceramide-dependent and -independent mitogen-activated protein kinase cascades. J Biol Chem (1996) 1.47
Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. J Cell Biochem (2001) 1.41
Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med (2000) 1.35
Structure and function of fibronectin modules. Matrix Biol (1996) 1.34
Molecular variants of fibronectin and laminin: structure, physiological occurrence and histopathological aspects. Virchows Arch (1996) 1.25
Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int (2004) 1.17
Plasma fibronectin deficiency impedes atherosclerosis progression and fibrous cap formation. EMBO Mol Med (2012) 1.16
Stretching fibronectin. J Muscle Res Cell Motil (2002) 1.14
Modulation of cell-extracellular matrix interactions. Ann N Y Acad Sci (1998) 1.05
NF-kappaB in cardiovascular disease: diverse and specific effects of a "general" transcription factor? Cardiovasc Toxicol (2005) 1.04
Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol (2009) 1.03
Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin (2012) 1.03
Aqueous extract of Salvia miltiorrhiza attenuates increased endothelial permeability induced by tumor necrosis factor-alpha. Int Immunopharmacol (2005) 0.96
Protocatechuic aldehyde suppresses TNF-alpha-induced ICAM-1 and VCAM-1 expression in human umbilical vein endothelial cells. Eur J Pharmacol (2005) 0.95
Herbal remedies supply a novel prospect for the treatment of atherosclerosis: a review of current mechanism studies. Phytother Res (2011) 0.94
Atherosclerosis: humoral and cellular factors of inflammation. Virchows Arch (2005) 0.91
Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction. Chin Med (2010) 0.90
Salvianolic acid B attenuates plasminogen activator inhibitor type 1 production in TNF-alpha treated human umbilical vein endothelial cells. J Cell Biochem (2005) 0.88
Computational pharmacological comparison of Salvia miltiorrhiza and Panax notoginseng used in the therapy of cardiovascular diseases. Exp Ther Med (2013) 0.86
Doinseunggitang ameliorates endothelial dysfunction in diabetic atherosclerosis. Evid Based Complement Alternat Med (2013) 0.84
Cryptotanshinone inhibits endothelin-1 expression and stimulates nitric oxide production in human vascular endothelial cells. Biochim Biophys Acta (2005) 0.83
Salvia miltiorrhiza inhibits intimal hyperplasia and monocyte chemotactic protein-1 expression after balloon injury in cholesterol-fed rabbits. J Cell Biochem (2001) 0.83
Protective effect of Xin Mai Jia ultrafiltration extract on human umbilical vein endothelial cell injury induced by hydrogen peroxide and the effect on the NO-cGMP signaling pathway. Exp Ther Med (2014) 0.82
Atherosclerosis is an inflammatory disease. Semin Immunopathol (2009) 0.82
Changes in markers of vascular injury in response to transient hyperhomocysteinemia. Metabolism (2003) 0.78
Inducible nitric oxide synthase modulates fibronectin production in the EA.hy926 cell line and cultured human umbilical vein endothelial cells. J Cardiovasc Pharmacol (1994) 0.78